Heranba Industries Limited HERANBAshare price and chart
Heranba Industries closed at ₹147.16 on 19 November 2026, up 0.36% on the day. The 52-week range is ₹144.20 to ₹266.30.
Daily candlesEach candle is one trading day. The chart opens on the last year; drag back past the start or open full screen and the rest loads, back to listing (or the first day in our data). The body runs from the open to the close, the thin lines to the high and low. Green closed up, red closed down.
Loading prices…
Split and bonus adjusted daily candles. Drag back past the start, or open full screen, and its whole history loads. Scroll or pinch to zoom; full screen adds indicators, drawing and measuring.Test a strategy on HERANBA
Real prices, every charge counted. Pick one or write your own.Heranba Industries makes insecticides, herbicides, fungicides and public health products from four plants, selling in India to farmers, retailers, wholesalers and distributors through stock depots, and exporting 28.5% of turnover to 85 countries.
Fertilizers & Agrochemicals
Insecticides, herbicides, fungicides, public health products
Farmers, retailers, wholesalers, distributors
Technical snapshotHow the share has been behaving: its momentum, its trend, how much of the trading was real buying to keep, and its returns.
EOD 19 NovThe share of traded quantity that was actually delivered (not squared off intraday) - high delivery vs its 20-session average suggests real buying or holding, not just churn.
Returns and valuationWhat the market pays for this company and how well the business uses its money.
Books to 30 Sept 2026Against its sectorWhere this company ranks among similar companies on each measure.
Pesticides & Agrochemicals · 25 peers · mediansWhat the numbers sayShort plain statements about this company's latest figures.
Written by fixed rulesLatest quarterIn the quarter to September 2026 (results filed 7 Nov 2026), sales fell 28.7% from a year earlier to ₹372 cr and profit turned positive at ₹2.6 cr after a loss of ₹2.1 cr a year earlier.
- Sales grew 3 years running (₹1,070 cr in FY23 to ₹1,595 cr in FY26).
- Profit fell 4 years running (₹189 cr in FY22 to -₹77.6 cr in FY26).
- Reported a loss in FY26.
- Operating margin fell from 12.6% in FY23 to 4.3% in FY26.
- Profit before interest covered interest -0.4 times in FY26 (₹50 cr of interest).
- Return on equity stayed under 10% from FY24 to FY26 (highest 4.2%).
Each line is written by a fixed rule from the company's own filings and share price, and names the figures it uses. It describes what happened; it is not advice about the share.
Share price reaction to resultsWhat the share price did around each recent quarterly result.
Over the last 20 results, the share rose on 5 and fell on 15, and moved by 3% or more on 14.
Q2 FY27: results filed 7 Nov 2026. The share went from its close on 6 Nov 2026 to its close on 8 Nov 2026 -1.43%.
Dividend historyCash the company has paid per share, year by year.
2025 paid ₹1.00 per share, about ₹680 on ₹1 lakh at today's price. Dividends are at the company's discretion and can be cut or skipped.
What it has returnedThe yearly growth rate in the share price over each period, as if it had grown smoothly.
Price only, before dividendsHeld for 5 years this compounded at -26.2% a year. The last twelve months were down -43.6%. Price only, before dividends.
Shareholding patternThe share of the company held by its promoters, by foreign and domestic institutions, and by the public, quarter by quarter.
Who owns itEach line is that holder's share of all shares over the last 6 quarters, drawn to its own scale - the printed change is the size of the move. Mutual funds and insurers sit inside the domestic figure; hover the bar above for that split.
The promoter/promoter-group stake as a percentage of total shares, each quarter since listing. A rising line means promoters are adding to their stake; a falling one often means dilution, pledge-driven sales, or stake sales to new investors.
Recent announcementsThe company's own filings to the exchange in the last six months: results, board meetings, investor calls and more, each with its source document.
Last 6 monthsKey ratios at a glanceThe eight figures most people check first, each placed against companies in the same industry.
Against its sectorPeers are the listed companies in the exchange's own industry group: Pesticides & Agrochemicals. Balance-sheet figures are from the latest filed balance sheet; trends show each financial year we hold.
Revenue and profit, year by yearSales and net profit by financial year or by quarter.
Sales and net profitWhere every ₹100 of sales goesHow each ₹100 the company sold was spent, and how much stayed as profit.
FY26In FY26, of every ₹100 of sales it kept ₹0.0 as profit.
How fast it has grownCompound growth a year in sales and profit, over 3 and 5 financial years, beside the latest quarter.
Compounded a yearCash flowProfit is an accounting figure. Cash flow shows the money that really moved: in from the business, out on investments, and to or from lenders and shareholders.
Where the cash wentIn FY26 cash fell by ₹19 Cr, after ₹92 Cr spent on plant and equipment.
Health check, year by yearMargins, returns and debt for each financial year, so you can see the direction.
| Measure | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Sales growthSales in this financial year against the previous one. | -26.2% | 17.4% | 12.1% | 13.1% |
| Operating marginOf every ₹100 of sales, the profit from the main business before depreciation, interest and tax. | 12.6% | 6.1% | 6.9% | 4.3% |
| Net marginOf every ₹100 of sales in the year, how much was left as profit after everything. | 8.7% | 2.7% | 0.2% | -4.9% |
| ROEHow much profit the company made on the shareholders' money in the business. 15% means ₹15 of profit a year on every ₹100 of owners' money. | 11.5% | 4.2% | 0.3% | -9.6% |
| ROCEHow much operating profit the company made on all the money in the business, whether it came from owners or lenders. | 16.2% | 6.8% | 4.5% | -1.6% |
| Debt to equityBorrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings. | 0.11x | 0.19x | 0.41x | 0.74x |
| Interest coverHow many times the company's profit before interest could pay its interest bill. | 21.8x | 5.2x | 1.6x | -0.4x |
Each row against this company's own usual level: green better, red worse, grey close to it.
Peers side by sideCompanies in the same exchange-defined industry group, largest first. Tap a heading to sort.
Pesticides & Agrochemicals| Company | What the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality. | How many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit. | The share price against the shareholders' money per share on the balance sheet. It asks what you pay for each rupee the owners have in the business. | How much profit the company made on the shareholders' money in the business. 15% means ₹15 of profit a year on every ₹100 of owners' money. | How much operating profit the company made on all the money in the business, whether it came from owners or lenders. | Borrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings. | Of every ₹100 of sales, how much is left as profit after all costs, interest and tax. | How much sales grew in the latest quarter against the same quarter a year earlier. | The cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share. |
|---|---|---|---|---|---|---|---|---|---|
| UPL UPL Limited | 48,101 cr | 26.4x | 1.4x | 5.6% | 10.8% | 0.79 | 4.1% | -1.3% | 1.05% |
| PIIND PI Industries Limited | 24,730 cr | 28.2x | 2.2x | 12.3% | 15.7% | 0.02 | 13.8% | -9.1% | 0.92% |
| SUMICHEM Sumitomo Chemical India Limited | 17,178 cr | 30.8x | 4.7x | 17.2% | 23.3% | 0.00 | 17.4% | -2.4% | 0.38% |
| BAYERCROP Bayer Cropscience Limited | 15,048 cr | 20.2x | - | - | - | - | 14.1% | -19.5% | 4.48% |
| SHARDACROP Sharda Cropchem Limited | 6,054 cr | 9.4x | 1.9x | 24.2% | 30.4% | 0.00 | 11.8% | +13.2% | 2.24% |
| DHANUKA Dhanuka Agritech Limited | 4,092 cr | 14.6x | 2.3x | 18.6% | 24.4% | 0.00 | 14.1% | +9.9% | 0.22% |
| RALLIS Rallis India Limited | 3,681 cr | 18.7x | 1.7x | 9.3% | 12.9% | 0.00 | 6.7% | -0.3% | 1.59% |
| NACLIND NACL Industries Limited | 2,753 cr | 367.3x | 3.9x | 0.8% | 6.2% | 0.51 | 0.6% | -18.1% | 0.00% |
| BHAGCHEM Bhagiradha Chemicals & Industries Limited | 2,376 cr | 86.4x | 3.3x | 2.6% | 4.5% | 0.51 | 4.3% | +21.3% | 0.08% |
| GSPCROP GSP Crop Science Limited | 1,890 cr | 21.4x | 2.3x | 12.3% | 15.9% | 0.34 | 5.2% | - | 0.25% |
| INSECTICID Insecticides (India) Limited | 1,566 cr | 12.8x | 1.2x | 12.1% | 15.9% | 0.18 | 5.8% | +7.6% | 1.30% |
| BHARATRAS Bharat Rasayan Limited | 1,542 cr | 11.3x | 1.2x | 12.1% | 15.7% | 0.04 | 10.8% | +23.4% | 0.05% |
| IPL India Pesticides Limited | 1,430 cr | 15.1x | 1.4x | 12.6% | 16.8% | 0.08 | 9.7% | -21.2% | 0.60% |
| MOL Meghmani Organics Limited | 1,364 cr | 15.7x | 0.8x | 1.9% | 6.7% | 0.41 | 4.0% | +15.5% | 0.00% |
| ASTEC Astec LifeSciences Limited | 1,231 cr | - | 3.7x | -25.8% | -5.7% | 0.99 | -18.1% | -2.3% | 0.00% |
| PUNJABCHEM Punjab Chemicals & Crop Protection Limited | 1,071 cr | 17.8x | 2.4x | 16.2% | 18.2% | 0.65 | 5.3% | +28.0% | 0.34% |
| DHARMAJ Dharmaj Crop Guard Limited | 833 cr | 14.9x | 1.7x | 13.0% | 16.4% | 0.24 | 4.9% | -4.2% | 0.00% |
| ADVANCE Advance Agrolife Limited | 791 cr | 17.9x | 2.3x | 11.4% | 13.9% | 0.32 | 5.1% | +35.0% | 0.00% |
| HERANBA Heranba Industries Limited | 589 cr | - | 0.8x | -9.6% | -1.6% | 0.60 | -5.2% | -28.7% | 0.00% |
| BESTAGRO Best Agrolife Limited | 519 cr | 10.8x | 0.6x | 1.2% | 5.2% | 0.53 | 4.1% | -21.2% | 0.68% |
| SHIVALIK Shivalik Rasayan Limited | 459 cr | 32.3x | 0.7x | 3.2% | 4.6% | 0.17 | 5.4% | +7.2% | 0.17% |
| IGCL Indogulf Cropsciences Limited | 379 cr | 7.8x | 0.8x | 10.9% | 12.3% | 0.43 | 6.3% | +3.0% | 0.00% |
| SIKKO Sikko Industries Limited | 226 cr | 36.9x | 2.4x | 6.1% | 7.8% | 0.07 | 9.4% | +21.3% | 0.00% |
| CLSL Crop Life Science Limited | 162 cr | - | - | - | - | - | - | - | 0.00% |
| ARISTO Aristo Bio-Tech And Lifescience Limited | 86 cr | 10.9x | 1.8x | - | 19.5% | 0.75 | 2.6% | -22.7% | 0.47% |
| DHANSA Dhansa Labs Limited | 59 cr | 9.9x | 0.6x | - | 8.4% | 0.82 | 3.9% | - | 0.00% |
Swipe the table sideways for more columns. Tap a heading to sort. A dash means the figure is not filed or cannot be worked out for that company. A bigger cohort is cut to its 40 largest companies.
Monthly price changeThe share's price change in every calendar month, one row per year, so you can check for yourself whether a month has a pattern.
Month by month| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -11.0 | -5.2 | -24.4 | +39.1 | -18.8 | +0.9 | +0.0 | -3.9 | +2.3 | -17.9 | +1.5 | · | -40.5% 11m |
| 2025 | -18.2 | -29.1 | -10.2 | +19.4 | +15.4 | +16.6 | +12.6 | -8.6 | -16.9 | +2.3 | -14.7 | -3.3 | -39.6% |
| 2024 | -5.0 | -5.2 | -20.8 | +16.4 | -11.2 | +19.8 | +13.3 | +26.4 | -5.2 | +1.8 | -2.7 | -13.3 | +2.9% |
| 2023 | -29.6 | -9.7 | -11.9 | +28.9 | -10.0 | +18.3 | -2.4 | -3.3 | -0.5 | -1.6 | -1.3 | +13.6 | -20.3% |
| 2022 | +6.2 | -18.1 | +3.1 | +1.8 | -7.0 | -3.8 | +3.0 | -1.9 | -2.8 | -5.9 | +5.4 | -7.0 | -26.0% |
| 2021 | · | · | · | +13.3 | +2.0 | -4.8 | +16.6 | +0.1 | -1.6 | -11.4 | -8.2 | +4.0 | +6.9% 9m |
Month-on-month change in closing price, adjusted for splits and bonuses but not for dividends, so a large dividend shows up here as a fall. Starts from 1995, when the exchange began trading equities, or from the stock's listing if later. This is a record of what happened, not a forecast.
Deals and filingsLarge trades reported to the exchange, plus the company's documents sorted by type.
| Date | Party | Side | Quantity | Price | Value |
|---|---|---|---|---|---|
| 2026-09-25 | NK SECURITIES RESEARCH PRIVATE LIMITED · bulk | BUY | 2,06,732 | ₹193.36 | ₹4.00 Cr |
| 2026-09-25 | NK SECURITIES RESEARCH PRIVATE LIMITED · bulk | SELL | 2,06,732 | ₹193.59 | ₹4.00 Cr |
| 2024-08-28 | GRAVITON RESEARCH CAPITAL LLP · bulk | SELL | 2,84,100 | ₹512.96 | ₹14.57 Cr |
| 2024-08-28 | GRAVITON RESEARCH CAPITAL LLP · bulk | BUY | 2,84,100 | ₹512.49 | ₹14.56 Cr |
| 2024-08-13 | GRAVITON RESEARCH CAPITAL LLP · bulk | BUY | 2,77,159 | ₹465.49 | ₹12.90 Cr |
| 2024-08-13 | GRAVITON RESEARCH CAPITAL LLP · bulk | SELL | 2,75,784 | ₹466.38 | ₹12.86 Cr |
| 2024-08-12 | GRAVITON RESEARCH CAPITAL LLP · bulk | SELL | 2,42,527 | ₹438.60 | ₹10.64 Cr |
| 2024-08-12 | GRAVITON RESEARCH CAPITAL LLP · bulk | BUY | 2,41,153 | ₹438.83 | ₹10.58 Cr |
- Board outcomeOutcome of Board Meeting7 Nov 2026
Heranba Industries Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
- Board outcomeOutcome of Board Meeting22 Aug 2026
Heranba Industries Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
- Board outcomeOutcome of Board Meeting28 May 2026
Heranba Industries Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
- Board outcomeOutcome of Board Meeting11 Feb 2026
Heranba Industries Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
- Board outcomeOutcome of Board Meeting14 Nov 2025
Heranba Industries Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.
- Board outcomeOutcome of Board Meeting12 Aug 2025
Heranba Industries Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.
- Board outcomeOutcome of Board Meeting23 May 2025
Heranba Industries Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025.
- Integrated Filing- Financial14 Feb 2025
Integrated filing of Financials - Unaudited Standalone and Consolidated Financial Results for the Quarter and nine months ended 31.12.2024 and Limited Review Reports of the Auditors thereon
- Press releasePress Release14 Feb 2025
Heranba Industries Limited has informed the Exchange regarding a press release dated February 14, 2025, titled "Press Release on Financial Result Q3FY25 ".
- Financial Result Updates14 Feb 2025
Heranba Industries Limited has submitted to the Exchange, the financial results for the period ended December 31, 2024.
The last two years of the company's filings to the exchange, grouped by the exchange's own categories. Each opens the original document.
Read enough? Test HERANBA. “Buy HERANBA when RSI(14) drops below 30, sell at 10% profit or after 20 days.” Real prices, every charge counted.
Run it free